Day Two: 2025 Life Science, Digital & Health Open Innovation Forum

Day Two: 2025 Life Science, Digital & Health Open Innovation Forum Life Science, Digital & Health Open Innovation Forum in London 2025

We held ‘UK, Korea, and Japan - Life Science, Digital & Healthcare Open Innovation Forum’ on March 4th in London.

The Forum focused on bringing together leading Korean and Japanese LPs, CVCs, Global GPs, and drug discovery enterprises to foster cross-border collaboration, drive investment, and accelerate the growth of life science opportunities in the UK on a global scale.

As Europe’s largest venture capital market, the UK is a premier hub for life science investment, R&D, and open innovation, supported by world-class academic institutions and a thriving spin-out, and investment landscape.

Aligned with the UK Government’s vision to advance the life science-digital-healthcare investment environment, the Forum will unite top-tier international and local investors, innovators, and industry leaders in dedication to share valuable insights, identify emerging trends, and establish strategic collaborations.

Ultimately, we hoped it had served as a platform for developing a strategic investment ecosystem that will shape the future of bio-healthcare innovation.

From left: Mr. Jamie Heath (CFO, Apollo Therapeutics) / Prof.Kei Cho (King's College London), Mr. Ryo Tsuji (Deputy General Manager, ITOCHU Corporation), Dr.Akihiro Imura (CEO, COGNANO), Dr. Ollie Hardick (Entrepreneur in Residence, M Ventures), Dr. Hiroyuki Usuda (Scouting and Transaction Lead, Astellas), Ms.Eun-Young Jeung (Director General, Ministry of Health and Welfare), Dr. Giovanna Lalli, (Director of Strategy & Operation, LifeArc), Dr. Daniel Ring (VP, AviadoBio, Mr. Masahide Sakishige, (Deputy Director General, Japan External Trade Organisation - London), Dr. Junghwan Park (Deputy Director, Division of Health Industry Policy, Ministry of Health and Welfare, Korea), Mr. Jonathan Crook (Deputy Head, Venture Capital Unit, Department for Business & Trade)

Panel discussion led by Dr. Hiroki Takai (Global Brain)